Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Phase III Study of BKM120/Placebo With Fulvestrant in Postmenopausal Patients With Hormone Receptor Positive HER2-negative Locally Advanced or Metastatic Breast Cancer Refractory to Aromatase Inhibitor

ClinicalTrials.gov ID: NCT01610284

Public ClinicalTrials.gov record NCT01610284. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 18, 2026, 11:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III Randomized, Double Blind Placebo Controlled Study of BKM120 With Fulvestrant, in Postmenopausal Women With Hormone Receptor-positive HER2-negative Locally Advanced or Metastatic Breast Cancer Which Progressed on or After Aromatase Inhibitor Treatment

Study identification

NCT ID
NCT01610284
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Novartis Pharmaceuticals
Industry
Enrollment
1,147 participants

Conditions and interventions

Conditions

Not listed

Interventions

Not listed

Eligibility (public fields only)

Age range
18 Years and older
Sex
Female
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 6, 2012
Primary completion
Apr 28, 2015
Completion
Apr 18, 2019
Last update posted
Aug 24, 2020

2012 – 2019

United States locations

U.S. sites
61
U.S. states
28
U.S. cities
54
Facility City State ZIP Site status
University of South Alabama / Mitchell Cancer Institute Deptof Mitchell Cancer Inst(2) Mobile Alabama 36688
Arizona Oncology Associates Dept of Oncology Phoenix Arizona
Highlands Oncology Group Fayetteville Arkansas 72703
Shapiro and Stafford and Yee and Polanski Study Coordinator Arcadia California 91007
Cancer Care Associates Dept.ofCancerCareAssoc. Fresno California 93720
St. Jude Heritage Medical Group Virginia Crosson Cancer Center Fullerton California 92835
University of California San Diego - Moores Cancer Center UCSD 3 La Jolla California 92093-0658
Los Angeles Hematology/Oncology Medical Group LA Cancer Network Los Angeles California 90017
USC Kenneth Norris Comprehensive Cancer Center Dept.ofNorrisCompCancerCtr (3) Los Angeles California 90053
University of California at Los Angeles Dept. of UCLA Los Angeles California 90095
Ventura County Hematology and Oncology PMK Medical Group Oxnard California 93030
Coastal Integrative Cancer Care San Luis Obispo California 93401
Santa Barbara Hematolgy Oncology Medical Group Santa Barbara California 93105
Central Coast Medical Oncology Corporation Santa Maria California 93454
St Joseph Heritage Healthcare Dept. of RRMG (4) Santa Rosa California 94503
Granada Hills Cancer Center Valencia California 91355
Kaiser Permanente Northwest Kaiser Denver Colorado
Rocky Mountain Cancer Centers RMCC Greenwood Village Colorado
Memorial Regional Cancer Center MRCC Hollywood Florida 33021
Cancer Specialists of North Florida SC - F2302 Jacksonville Florida 32258
University of Miami Univ Miami 2 Miami Florida 33136
MD Anderson Cancer Center - Orlando MD Orlando Orlando Florida 32806
Georgia Cancer Specialists SC Decatur Georgia 30033
North Shore University Health System Evanston Illinois 60201
Cadence Health Geneva Illinois 60134
Cancer Care and Hematology Specialists of Chicagoland Niles Multiple Locations Illinois
Cancer Center of Kansas CCK Wichita Kansas 67214-3728
Mercy Medical Center Mercy Medical SC Baltimore Maryland 21202
Sidney Kimmel Comprehensive Cancer Center Johns Hopkins Med Sidney/John Hopkins Baltimore Maryland 21231
Frederick Memorial Hospital Fred. Mem. Hosp. Frederick Maryland 21701
Maryland Oncology Hematology, P.A. SC Rockville Maryland 20850
Massachusetts General Hospital SC Boston Massachusetts 02114
West Michigan Cancer Center Dept of Oncology Kalamazoo Michigan 49007
Hematology and Oncology Association at Bridgepoint Hem Onc Bridgepoint Tupelo Mississippi 38801
Washington University School of Medicine Regulatory St Louis Missouri 63110
Hackensack Meridian Health Brick New Jersey 08724
The Valley Hospital / Luckow Pavillion Paramus New Jersey 07652
Clinical Research Alliance SC-2 Lake Success New York 11042
Memorial Sloan Kettering Dept Onc New York New York 10017
University of Rochester Medical Center Univ Rochester Rochester New York 14642
Levine Cancer Institute Levine Cancer Institute Charlotte North Carolina 28203
Wake Forest University Health Sciences Winston-Salem North Carolina 27157
Case Western Reserve SC Cleveland Ohio 44106-5000
Northwest Cancer Specialists Portland Loc Portland Oregon 97210
St. Luke's Hospital and Health Network St Luke's (2) Bethlehem Pennsylvania 18015
Charleston Hematology Oncology Association PA Charleston South Carolina 29414
Tennessee Cancer Specialists Knoxville Tennessee 37909
Vanderbilt University Medical Center Vanderbilt - Thompson Ln Nashville Tennessee 37232
Texas Oncology P A Midtown Dallas Texas 75251
Texas Oncology P A TX Onc - Bedford Dallas Texas 75251
Texas Oncology P A TX Onc - Med City Dallas Dallas Texas 75251
Texas Oncology P A TX Onc - Southwest Dallas Texas 75251
Oncology Consultants Oncology Consultants, P.A. Houston Texas 77024
Cancer Therapy and Research Center UT Health Science Center Institute for Drug Development San Antonio Texas 78229
Utah Cancer Specialists Dept.of Utah Cancer Spec. (3) Salt Lake City Utah 84106
Oncology Hematology Associates of Southeast Virginia Salem VA Branch Roanoke Virginia 24014
Kadlec Clinic Hematology and Oncology Kadlec Clinic Hematology & Onc Kennewick Washington 99336
West Virginia University/ Mary Babb Randolph Cancer Center Dept of Oncology Morgantown West Virginia 26506
Cancer TEAM Bellin Health Belin Health Green Bay Wisconsin 54313
Dean Health System Dean Hematology Oncology Madison Wisconsin 53717
University of Wisconsin / Paul P. Carbone Comp Cancer Center Univ Wisc 3 Madison Wisconsin 53792-6164

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 109 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01610284, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 24, 2020 · Synced May 18, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01610284 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →